Monthly Archives

October 2016

CluePoints Introduces Data Quality Oversight Service for Site Inspection Readiness

By | Blog, News, Site Inspection Readiness | No Comments

31 October 2016

Cambridge, MACluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADARTM, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.…

FDA Signs Agreement with CluePoints to Explore a Data-Driven Approach to Quality Oversight in Clinical Trials

By | Blog, News, Uncategorized | No Comments

12 October 2016

Cambridge, MA –  FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research.  Misconduct in clinical research, including, but not limited to the falsification or omission of data in reporting research results, places all subjects in that trial at possible safety risk. 

CluePoints Teams up with Paragon Solutions to Share the Secrets of Successful Risk-Based Monitoring Implementation

By | Blog, News, Site Inspection Readiness | No Comments

We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration! Register now – this is THE Risk-Based Monitoring webinar that you need to attend.

About the Webinar

With regulatory bodies such as the FDA, EMA, and the ICH all strongly influencing sponsors to adopt a risk-based and centralized approach to site and data monitoring, sponsors are often left wondering how to implement this new paradigm most effectively.